InvestSMART

ImpediMed Limited (ASX: IPD) - Announcements

Current share price for IPD : $0.006 0.001 (20%)+

ASX company news and announcements for ImpediMed Limited (IPD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ImpediMed Limited (IPD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ImpediMed Limited (IPD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ImpediMed Limited (IPD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$22 Appendix 4E 31 Aug 2023 8:14AM $0.175 $0.006 fallen by 96.57%
$22 Response to Notice 249D from IPDs Executive Leadership Team 30 Aug 2023 8:08AM $0.175 $0.006 fallen by 96.57%
$22 Market Update - Executing Towards Profitability in Oncology 22 Aug 2023 8:04AM $0.190 $0.006 fallen by 96.84%
$22 Shareholder Letter 16 Aug 2023 2:23PM $0.200 $0.006 fallen by 97%
$22 Investor Conference Call 16 Aug 2023 2:18PM $0.205 $0.006 fallen by 97.07%
$22 Virtual Meeting Online Guide 16 Aug 2023 2:16PM $0.205 $0.006 fallen by 97.07%
$22 Statement from Dr Michael Seiden 16 Aug 2023 2:14PM $0.205 $0.006 fallen by 97.07%
$22 Statement from Janet West AM 16 Aug 2023 2:13PM $0.205 $0.006 fallen by 97.07%
$22 Response to Notice received under s249D of Corporations Act 16 Aug 2023 2:12PM $0.205 $0.006 fallen by 97.07%
$22 Notice of General Meeting and Voting Form 16 Aug 2023 2:11PM $0.205 $0.006 fallen by 97.07%
$22 Notice received under section 249D of the Corporations Act 3 Aug 2023 8:54AM $0.195 $0.006 fallen by 96.92%
$22 Becoming a substantial holder 1 Aug 2023 7:22PM $0.195 $0.006 fallen by 96.92%
$22 Five Additional Medical Policies Achieved 31 Jul 2023 2:48PM $0.195 $0.006 fallen by 96.92%
$22 Notice received under section 203D of the Corporations Act 31 Jul 2023 8:38AM $0.205 $0.006 fallen by 97.07%
$22 APPENDIX 4C - Quarterly Activities Report 24 Jul 2023 9:09AM $0.200 $0.006 fallen by 97%
$22 First Top 5 National Payor Covering SOZO Testing 19 Jul 2023 9:51AM $0.185 $0.006 fallen by 96.76%
$22 Quarterly Results and Investor Conference Call Notification 17 Jul 2023 8:22AM $0.175 $0.006 fallen by 96.57%
$22 Change of Director's Interest Notice - Mr Donald Williams 6 Jul 2023 8:20AM $0.200 $0.006 fallen by 97%
$22 Change of Director's Interest Notice - Mrs Janet West 6 Jul 2023 8:20AM $0.200 $0.006 fallen by 97%
$22 Change of Director's Interest Notice - Mr Amit Patel 6 Jul 2023 8:20AM $0.200 $0.006 fallen by 97%
$22 Change of Director's Interest Notice - Mr David Anderson 6 Jul 2023 8:20AM $0.200 $0.006 fallen by 97%
$22 Notice under section 708A(5)(e) of the Corporations Act 6 Jul 2023 8:20AM $0.200 $0.006 fallen by 97%
$22 Application for quotation of securities - IPD 6 Jul 2023 8:20AM $0.200 $0.006 fallen by 97%
$22 Initial Director's Interest Notice - Mr Daniel Sharp 3 Jul 2023 6:44PM $0.185 $0.006 fallen by 96.76%
$22 Initial Director's Interest Notice - Mr Michael Van Seiden 3 Jul 2023 6:44PM $0.185 $0.006 fallen by 96.76%

276 - 300 of 1211 results

Page 12 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.